Long-term health-related quality of life and tremor outcomes after unilateral versus bilateral vim/PSA deep brain stimulation for essential tremor: a registry-based comparative study
Background Deep brain stimulation (DBS) is an established treatment for medication-refractory essential tremor (ET); however, the long-term effects of unilateral DBS, particularly on health-related quality of life (HRQoL), have remained uncertain. Therefore, this study compared short-, mid-, and long-term HRQoL and tremor outcomes after unilateral versus bilateral ventralis intermedius/posterior subthalamic area (Vim/PSA) DBS. Methods In this single-centre, registry-based, retrospective study, prospectively collected data of 35 patients with ET were analysed to compare outcomes of unilateral versus bilateral Vim/PSA DBS. Outcomes were assessed at 1, 2–5, and ≥6 years. The primary outcome was HRQoL assessed by the Summary Index of the Quality of Life in Essential Tremor Questionnaire. Secondary outcomes included the 5-dimension 5-level European Quality of Life Questionnaire, Schwab and England Activities of Daily Living Scale, and Fahn-Tolosa-Marin Tremor Rating Scale Parts A, B, and C. Between-group differences were assessed using appropriate parametric and non-parametric tests, while longitudinal outcomes were analysed using repeated-measures ANOVA and ordinal logistic mixed-effects models. Results No significant between-group differences in HRQoL were observed at any follow-up. Bilateral DBS was associated with greater overall tremor reduction, with significant time×group interactions for the FTMTRS score at 1 ( p = 0.048), 2–5 ( p = 0.031), and ≥6 ( p = 0.041) years. Long-term axial tremor control also favoured bilateral DBS ( p < 0.001). In contrast, dominant-side tremor outcomes were comparable between groups, with no significant time×group interactions or group effects. Conclusion Bilateral DBS was associated with greater overall tremor reduction, whereas HRQoL and dominant-side tremor outcomes were comparable between unilateral and bilateral DBS groups across the examined follow-up periods. These findings suggest that unilateral DBS may also provide sustained HRQoL improvement in appropriately selected patients with ET; however, the retrospective design, limited sample size, and clinically selected treatment allocation may limit causal interpretation.
Authors
- Mirtill Rohonczi (ORCID: https://orcid.org/0009-0007-5982-7626)
- Dávid Pintér (ORCID: https://orcid.org/0000-0002-0734-6878)
- Márk Harmat
- Sahar Hemeda (ORCID: https://orcid.org/0009-0001-3322-1091)
- József Janszky
- Norbert Kovács
- István Balás
Institutions
- Hungarian Research Network (HU)
- University of Pecs (HU)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3389/fneur.2026.1988076
- Primary Topic
- Deep Brain Stimulation and Movement Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00